Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xizang Ganlu Tibetan Medicine and Herbal Resources Development is a specialized subsidiary of the Ganlu Tibetan Medicine Group, focused on the upstream supply chain of traditional Tibetan pharmaceuticals. Based in Lhasa, the company manages the cultivation, wild-collection, and primary processing of rare high-altitude medicinal herbs essential for traditional formulations. It plays a critical role in ensuring the sustainability and quality of raw materials for "National Treasure" medicines such as the 70-flavor Pearl Pill. The company integrates traditional ecological knowledge with modern agricultural standards to protect endangered Himalayan flora. Its operations are central to the Ganlu brand's reputation for authenticity and therapeutic efficacy in treating chronic and complex diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xizang Ganlu Tibetan Medicine and Herbal Resources Development.